Company / Gross Profit per Share
Exelixis Gross Profit per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.60
FY2020
5-year range
-
FY2016-FY2020
Trend
+5.4%
vs FY2019
Sector context
#26 of 29
Health Care
What the data says
Among 29 Health Care companies, Exelixis is in the bottom 10% for gross profit per share. Improved from $0.31 to $0.60 over the past 2 years.
Based on SEC 10-K filings.
0.60 in FY2020 with a 3-year CAGR of +24.2%.
Improved from $0.31 to $0.60 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +24.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 29This company $0.60 Sector average $8.11
▼
-92.5% below sector average
Key checks
Key Insights
- In FY2020, gross profit per share increased 5.4% year-over-year.
- Ranks #26 out of 29 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.60 | +5.4% |
| FY2019 | $0.57 | +85.7% |
| FY2018 | $0.31 | -2.1% |
| FY2017 | $0.32 | +755.2% |
| FY2016 | $0.04 | -16.1% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026